Background: Gastrointestinal stromal tumors (GISTs) associated with neurofibromatosis are uncommon compared to their gastrointestinal counterparts. Patients with neurofibromatosis type 1 (NF-1) have an increased risk of developing gastrointestinal tumors, including rare types such as GIST.

Case Summary: A 60-year-old male Chinese patient was diagnosed with NF-1 10 years ago and presented with upper abdominal discomfort and black stools. Endoscopic ultrasonography and an enhanced abdominal computed tomography scan revealed a mass located 4 cm from the muscular layer of the descending duodenum. A 59-year-old Chinese woman who was diagnosed with NF-1 25 years ago presented with sudden unconsciousness and black stools. Multiple masses in the duodenum were noted by echogastroscopy and an enhanced abdominal computed tomography scan. Both patients presented with cutaneous neurofibromas. The histologic examination of tumors from both patients revealed spindle cells and low mitotic activity. Immunohistochemically, the tumor cells showed strong positivity for KIT (CD117), DOG-1, CD34, and Dehydrogenase Complex Subunit B, and negativity for SMA, desmin, S-100, and β-catenin. None of the six tumors from two patients had exon 9, 11, 13, or 17 or exon 12 or 18 mutation, which is a typical finding for sporadic GISTs. None of the six tumors from the two patients had a mutation. The patients were alive and well during the follow-up period (range: 0.6-5 yr).

Conclusion: There have been only a few previous reports of GISTs associated with NF-1. Although GISTs associated with NF-1 have morphologic and immunohistochemical similarities with GISTs, the pathogenesis, incidence, genetic background, and prognosis are not completely known. A medical history of NF-1 in a patient who has gastrointestinal bleeding or anemia and an intra-abdominal mass with nonspecific computed tomography features may help in diagnosing GIST by virtue of the well-known association of these two entities. Molecular genetic studies of cases indicated that GISTs in NF-1 patients have a different pathogenesis than sporadic GISTs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940329PMC
http://dx.doi.org/10.12998/wjcc.v7.i24.4398DOI Listing

Publication Analysis

Top Keywords

gists associated
12
computed tomography
12
tumors patients
12
gastrointestinal stromal
8
associated neurofibromatosis
8
neurofibromatosis type
8
diagnosed nf-1
8
nf-1 years
8
years ago
8
ago presented
8

Similar Publications

Background: Textbook outcome (TO) has been utilized to assess the quality of surgical care. This study aimed to define TO rates for minimally invasive gastric gastrointestinal stromal tumor (GIST) resections in a bi-institutional cohort.

Methods: Patients with gastric GIST (≤ 5 cm) who underwent laparoscopic or robotic resection (January 2014 to January 2024) were retrospectively identified from two GIST centers.

View Article and Find Full Text PDF
Article Synopsis
  • Gastrointestinal stromal tumors (GISTs) are rare cancers linked to mutations in the c-KIT gene, with one common mutation being a deletion in exon 11, as seen in an 82-year-old male patient diagnosed in June 2023.
  • The patient subsequently received a low-dose imatinib treatment protocol, starting at 400 mg/day and tapering down to 200 mg/day, which resulted in a reduction of the tumor size over several months.
  • The study suggests that low-dose imatinib can be an effective treatment option for GIST patients with the W557_K558 deletion, especially for those who cannot tolerate higher doses.
View Article and Find Full Text PDF

Gastrointestinal stromal tumor mimicking perineurioma: A case report.

Cytojournal

November 2024

Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.

Although gastrointestinal stromal tumor (GIST) can present with various histological characteristics, GIST mimicking perineurioma has not been previously reported. We present the case of a 47-year-old woman diagnosed with GIST after laparoscopic resection of a stomach tumor near the lesser curvature of the gastric body close to the cardia. Morphological features resembled a perineurioma.

View Article and Find Full Text PDF
Article Synopsis
  • Synovial sarcoma is a type of aggressive soft-tissue cancer with limited response to current immunotherapies, highlighting the need for better understanding of the immune cells in its tumor microenvironment.
  • Researchers studied 41 patients to analyze the relationship between immune cell types, tumor subtype (biphasic vs. monophasic), disease progression, and response to treatments like chemotherapy.
  • Findings indicated that biphasic synovial sarcomas had a higher presence of immune cells, particularly T cells, which correlated with better patient survival, suggesting they may respond more favorably to immunotherapies.
View Article and Find Full Text PDF

PCDHGA10 as a potential prognostic biomarker and correlated with immune infiltration in gastric cancer.

Front Immunol

December 2024

Department of General Surgery, Medical School of Nantong University, & Department of Gastrointestinal Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.

Background: Gastric cancer (GC) is one of the most common malignant tumors and is associated with poor prognosis. To improve the prognosis of GC patients, an effective immune-related prognostic biomarker is urgent. Here, we aim to explore the correlation between the expression of procalcitonin gamma subfamily A, 10 (PCDHGA10) and clinicopathological characteristics, especially its relation with tumor-infiltrating immune cells (TILs) in GC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!